dolasetron
| Form | Strength |
|---|---|
| SOLUTION, INTRAVENOUS | 20 mg/mL |
| Per policy, orders for these non-formulary agents will be changed to formulary equivalents. | |
|---|---|
| Non-Formulary Agent | Formulary Equivalent |
| dolasetron (Anzemet) 12.5 mg | ondansetron (Zofran) 4 mg IV q8h (prn) |